1 June 2018 - Deborah Wilkes
Archived
GlaxoSmithKline has now completed the buyout of Novartis' 36.5% stake in the consumer healthcare joint venture between the two companies for USD13.0 billion in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.